Sammons Cancer Center is a clinical research site located in Dallas, Texas, United States 75246.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Sammons Cancer Center has participated in 7 clinical trials.
Therapeutic areas: Melanoma, Advanced Melanoma, Metastatic Melanoma.
Sponsors: Regeneron Pharmaceuticals, Novartis Pharmaceuticals, Aegera Therapeutics.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Sammons Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sammons Cancer Center has 7 clinical trials on record. Their work covers Melanoma, Advanced Melanoma, Metastatic Melanoma.
Yes — Sammons Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.